Draulans N et al: Intrathecal baclofen in multiple sclerosis and spinal cord injury: Complications and long-term dosage evolution. Clin Rehabil 2013;27:1137.
Frydrych V, Oderda G: Skeletal muscle relaxants drug class review: University of Utah College of Pharmacy. Final Report 2016. Retrieved from https://www. medicaid.utah.gov/pharmacy/.
Gracies JM, Singer BJ, Dunne JW: The role of botulinum toxin injections in the management of muscle overactivity of the lower limb. Disabil Rehabil 2007;29:1789.
Groves L, Shellenberger MK, Davis CS: Tizanidine treatment of spasticity: A meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Adv Ther 1998;15:241.
Jankovic J: Medical treatment of dystonia. Mov Disord 2013;28:1001.
Kheder A, Nair KPS: Spasticity: Pathophysiology, evaluation and management. Pract Neurol 2012;12:289.
Krause T et al: Dantrolene—A review of its pharmacology, therapeutic use and new developments. Anaesthesia 2004;59:364.
Lopez JR et al: Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia. Anesthesiology 1992;76:711.
Lovell BV, Marmura MJ: New therapeutic developments in chronic migraine. Curr Opin Neurol 2010;23:254.
Malanga G, Reiter RD, Garay E: Update on tizanidine for muscle spasticity and emerging indications. Expert Opin Pharmacother 2008;9:2209.
Mast N, Linger M, Pikuleva IA: Inhibition and stimulation of activity of purified recombinant CYP11A1 by therapeutic agents. Mol Cell Endocrinol 2013;371:100.
Mirbagheri MM, Chen D, Rymer WZ: Quantification of the effects of an alpha-2 adrenergic agonist on reflex properties in spinal cord injury using a system identification technique. J Neuroeng Rehabil 2010;7:29.
Neuvonen PJ: Towards safer and more predictable drug treatment—Reflections from studies of the First BCPT Prize awardee. Basic Clin Pharmacol Toxicol 2012;110:207.
Nolan KW, Cole LL, Liptak GS: Use of botulinum toxin type A in children with cerebral palsy. Phys Ther 2006;86:573.
Reeves RR, Burke RS: Carisoprodol: Abuse potential and withdrawal syndrome. Curr Drug Abuse Rev 2010;3:33.
Ronan S, Gold JT: Nonoperative management of spasticity in children. Childs Nerv Syst 2007;23:943.
Ross JC et al: Acute intrathecal baclofen withdrawal: A brief review of treatment options. Neurocrit Care 2011;14:103.
Vakhapova V, Auriel E, Karni A: Nightly sublingual tizanidine HCl in multiple sclerosis: Clinical efficacy and safety. Clin Neuropharmacol 2010;33:151.
Verrotti A et al: Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol 2006;34:1.